Cargando…

Elevated LILRB1 expression predicts poor prognosis and is associated with tumor immune infiltration in patients with glioma

BACKGROUND: Leukocyte immunoglobulin-like receptor subfamily B1 (LILRB1) is regarded as an inhibitory molecule. However, the importance of LILRB1 expression in glioma has not yet been determined. This investigation examined the immunological signature, clinicopathological importance and prognostic v...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zou, Renheng, Zhong, Xunlong, Liang, Kairong, Zhi, Cheng, Chen, Danmin, Xu, Zhichao, Zhang, Jingbai, Liao, Degui, Lai, Miaoling, Weng, Yuhao, Peng, Huaidong, Pang, Xiao, Ji, Yunxiang, Ke, Yanbin, Zhang, Hongri, Wang, Zhaotao, Wang, Yezhong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10161664/ https://www.ncbi.nlm.nih.gov/pubmed/37142967 http://dx.doi.org/10.1186/s12885-023-10906-2

Ejemplares similares

GPR37 expression as a prognostic marker in gliomas: a bioinformatics-based analysis
por: Liang, Kairong, et al.
Publicado: (2023)

Comprehensive analysis of the prognostic and immunological signature of eight Tripartitemotif (TRIM) family molecules in human gliomas
por: Lu, Jiajie, et al.
Publicado: (2023)

Elevated TYROBP expression predicts poor prognosis and high tumor immune infiltration in patients with low-grade glioma
por: Lu, Jiajie, et al.
Publicado: (2021)

Clemastine promotes recovery of neural function and suppresses neuronal apoptosis by restoring balance of pro-inflammatory mediators in an experimental model of intracerebral hemorrhage
por: Zhi, Cheng, et al.
Publicado: (2021)

3BDO inhibits the proliferation, epithelial-mesenchymal transition (EMT), and stemness via suppressing survivin in human glioblastoma cells
por: Wang, Zhaotao, et al.
Publicado: (2022)

Neural stem cell-derived exosomes transfer miR-124-3p into cells to inhibit glioma growth by targeting FLOT2
por: Qian, Cheng, et al.
Publicado: (2022)

LILRB3 suppresses immunity in glioma and is associated with poor prognosis
por: Zhuang, Qiyuan, et al.
Publicado: (2023)

LILRB4 signaling in leukemia cells mediates T cell suppression and tumor infiltration
por: Deng, Mi, et al.
Publicado: (2018)

Hsa_circ_0076931 suppresses malignant biological properties, down-regulates miR-6760-3p through direct binding, and up-regulates CCBE1 in glioma
por: Ke, Yanbin, et al.
Publicado: (2022)

Paeoniflorin Inhibits EMT and Angiogenesis in Human Glioblastoma via K63-Linked C-Met Polyubiquitination-Dependent Autophagic Degradation
por: Liu, Zhi, et al.
Publicado: (2022)

The impact of HLA-G, LILRB1 and LILRB2 gene polymorphisms on susceptibility to and severity of endometriosis
por: Bylińska, Aleksandra, et al.
Publicado: (2017)

Molecular regulatory mechanism of LILRB4 in the immune response
por: LIU, Haiyin, et al.
Publicado: (2023)

Structures of the four Ig-like domain LILRB2 and the four-domain LILRB1 and HLA-G1 complex
por: Wang, Qihui, et al.
Publicado: (2019)

LILRB4, an immune checkpoint on myeloid cells
por: Yang, Ting, et al.
Publicado: (2022)

Prognostic impact of LILRB4 expression on tumor‐infiltrating cells in resected non‐small cell lung cancer
por: Kumata, Sakiko, et al.
Publicado: (2023)

Prognostic and Immunological Role of PPP1R14A as a Pan-Cancer Analysis Candidate
por: Wang, Zhaotao, et al.
Publicado: (2022)

HLA-G, LILRB1 and LILRB2 Variants in Zika Virus Transmission from Mother to Child in a Population from South and Southeast of Brazil
por: de Moraes, Amarilis Giaretta, et al.
Publicado: (2022)

Association between 23 drugs and Parkinson's disease: A two‐sample Mendelian randomization study
por: Xie, Zhixin, et al.
Publicado: (2023)

Structural basis for RIFIN-mediated activation of LILRB1 in malaria
por: Harrison, Thomas E., et al.
Publicado: (2020)

Structural basis of malaria RIFIN binding by LILRB1-containing antibodies
por: Chen, Yiwei, et al.
Publicado: (2021)

YTHDF2 correlates with tumor immune infiltrates in lower-grade glioma
por: Lin, Xiangan, et al.
Publicado: (2020)

LILRA3 Binds Both Classical and Non-Classical HLA Class I Molecules but with Reduced Affinities Compared to LILRB1/LILRB2: Structural Evidence
por: Ryu, Myongchol, et al.
Publicado: (2011)

The inhibitory receptor LILRB4 (ILT3) modulates antigen presenting cell phenotype and, along with LILRB2 (ILT4), is upregulated in response to Salmonella infection
por: Brown, Damien P, et al.
Publicado: (2009)

LILRB2/PirB mediates macrophage recruitment in fibrogenesis of nonalcoholic steatohepatitis
por: Li, Dan-Pei, et al.
Publicado: (2023)

LILRB2-mediated TREM2 signaling inhibition suppresses microglia functions
por: Zhao, Peng, et al.
Publicado: (2022)

ANGPTL2/LILRB2 signaling promotes the propagation of lung cancer cells
por: Liu, Xiaoye, et al.
Publicado: (2015)

KIR, LILRB and their Ligands’ Genes as Potential Biomarkers in Recurrent Implantation Failure
por: Nowak, Izabela, et al.
Publicado: (2017)

Poor Prognosis and Therapeutic Responses in LILRB1-Expressing M2 Macrophages-Enriched Gastric Cancer Patients
por: Zhang, Yawei, et al.
Publicado: (2021)

Expression of the innate immune receptor LILRB5 on monocytes is associated with mycobacteria exposure
por: Hogan, Louise E., et al.
Publicado: (2016)

A common missense variant of LILRB5 is associated with statin intolerance and myalgia
por: K Siddiqui, Moneeza, et al.
Publicado: (2017)

LILRB4 suppresses immunity in solid tumors and is a potential target for immunotherapy
por: Sharma, Naveen, et al.
Publicado: (2021)

Perspectives of targeting LILRB1 in innate and adaptive immune checkpoint therapy of cancer
por: Zeller, Tobias, et al.
Publicado: (2023)

Distinct frequency patterns of LILRB3 and LILRA6 allelic variants in Europeans
por: Bashirova, Arman A., et al.
Publicado: (2022)

Antagonistic anti-LILRB1 monoclonal antibody regulates antitumor functions of natural killer cells
por: Chen, Heyu, et al.
Publicado: (2020)

LILRB2 Interaction with HLA Class I Correlates with Control of HIV-1 Infection
por: Bashirova, Arman A., et al.
Publicado: (2014)

LILRB3 (ILT5) is a myeloid cell checkpoint that elicits profound immunomodulation
por: Yeboah, Muchaala, et al.
Publicado: (2020)

Characterization of the Leucocyte Immunoglobulin-like Receptor B4 (Lilrb4) Expression in Microglia
por: Kretzschmar, Felix, et al.
Publicado: (2021)

Evidence for Epistatic Interaction between HLA-G and LILRB1 in the Pathogenesis of Nonsegmental Vitiligo
por: de Oliveira-Caramez, Maria Luiza, et al.
Publicado: (2023)

HLA-F and LILRB1 Genetic Polymorphisms Associated with Alloimmunisation in Sickle Cell Disease
por: Bernit, Emmanuelle, et al.
Publicado: (2023)

Decidual Macrophage Functional Polarization during Abnormal Pregnancy due to Toxoplasma gondii: Role for LILRB4
por: Li, Zhidan, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_k2nutaaga1m9nnq6oipojpgplf